NEM vs. RIGL
NEM (Newmont Corporation) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. NEM operates in Gold (Basic Materials), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, NEM returned 11.09%/yr vs 5.69%/yr for RIGL. At a 0.09 correlation, their price movements are largely independent.
Performance
NEM vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NEM achieves a -6.97% return, which is significantly higher than RIGL's -8.22% return. Over the past 10 years, NEM has outperformed RIGL with an annualized return of 11.09%, while RIGL has yielded a comparatively lower 5.69% annualized return.
NEM
- 1D
- 3.69%
- 1M
- -10.89%
- 6M
- -21.90%
- YTD
- -6.97%
- 1Y
- 56.15%
- 3Y*
- 31.74%
- 5Y*
- 12.17%
- 10Y*
- 11.09%
- ALL TIME*
- 4.80%
RIGL
- 1D
- -0.91%
- 1M
- 19.45%
- 6M
- 8.17%
- YTD
- -8.22%
- 1Y
- 100.66%
- 3Y*
- 44.61%
- 5Y*
- -1.22%
- 10Y*
- 5.69%
- ALL TIME*
- -10.38%
NEM vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NEM Newmont Corporation | -6.97% | 172.82% | -7.83% | -8.76% | -20.77% | 7.40% | 40.28% | 30.52% | -6.15% | 10.91% |
RIGL Rigel Pharmaceuticals, Inc. | -8.22% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between NEM and RIGL is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Nov 29, 2000 | 0.09 |
Fundamentals
NEM:
$98.74B
RIGL:
$727.32M
NEM:
$7.15
RIGL:
$18.94
NEM:
12.94
RIGL:
2.08
NEM:
0.34
RIGL:
0.00
NEM:
3.95
RIGL:
2.52
NEM:
$17.23B
RIGL:
$299.77M
NEM:
$8.97B
RIGL:
$279.95M
NEM:
$13.78B
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NEM vs. RIGL — Risk / Return Rank
NEM
RIGL
NEM vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Newmont Corporation (NEM) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NEM | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.26 | ||
| Sortino ratioReturn per unit of downside risk | -0.70 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.30 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 1.76 | 2.02 | -0.26 |
| Martin ratioReturn relative to average drawdown | 4.12 | 3.42 | +0.70 |
Loading charts...
Drawdowns
NEM vs. RIGL - Drawdown Comparison
The maximum NEM drawdown since its inception was -81.30%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for NEM and RIGL.
Loading charts...
Drawdown Indicators
| NEM | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.30% | -99.37% | +18.07% |
Max Drawdown (1Y)Largest decline over 1 year | -32.10% | -50.08% | +17.98% |
Max Drawdown (3Y)Largest decline over 3 years | -36.57% | -50.76% | +14.19% |
Max Drawdown (5Y)Largest decline over 5 years | -62.40% | -84.04% | +21.64% |
Max Drawdown (10Y)Largest decline over 10 years | -62.40% | -86.40% | +24.00% |
Current DrawdownCurrent decline from peak | -29.60% | -96.32% | +66.72% |
Average DrawdownAverage peak-to-trough decline | -41.34% | -90.93% | +49.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.66% | 29.50% | -15.84% |
Volatility
NEM vs. RIGL - Volatility Comparison
The current volatility for Newmont Corporation (NEM) is 11.04%, while Rigel Pharmaceuticals, Inc. (RIGL) has a volatility of 13.35%. This indicates that NEM experiences smaller price fluctuations and is considered to be less risky than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NEM | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.04% | 13.35% | -2.31% |
Volatility (6M)Calculated over the trailing 6-month period | 37.61% | 34.86% | +2.75% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.79% | 70.20% | -22.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.25% | 85.53% | -47.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.73% | 82.83% | -47.10% |
Dividends
NEM vs. RIGL - Dividend Comparison
NEM's dividend yield for the trailing twelve months is around 1.10%, while RIGL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NEM Newmont Corporation | 1.10% | 1.00% | 2.69% | 3.87% | 4.66% | 3.55% | 1.74% | 3.31% | 1.62% | 0.67% | 0.37% | 0.56% |
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NEM vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Newmont Corporation and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NEM and RIGL have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RIGL has higher volatility (13.35%) compared to NEM (11.04%). In terms of maximum drawdown, NEM dropped -81.30% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (1.44 vs 1.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NEM and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer